Rick Lapointe has been appointed vice president of technology and acquisitions at OSO BioPharmaceuticals Manufacturing. Mr. Lapointe will be responsible for working with the senior leadership team to increase the company’s capabilities, identify new business opportunities and develop strategies to meet the organization’s long-term business objectives. OSO BioPharmaceuticals is located in Albuquerque, NM at the site formerly owned by Catalent Pharma Solutions.
"Rick is a seasoned business development and operations executive with over 25 years of experience in biotechnology and pharmaceutical companies. His distinguished track record in the industry and extensive experience will be an invaluable resource to the company and broadens the executive management team at an important stage in the growth of our business," said Milton Boyer, vice president of business development and sales for OsoBio. “We are pleased to welcome Rick to the OsoBio team.”
Prior to joining the company, Mr. Lapointe served as head of contract manufacturing at HollisterStier Laboratories and director of manufacturing at Bayer.